A Case of Hodgkin Lymphoma Developed in an Ataxia-telangiectasia Patient / 임상소아혈액종양
Clinical Pediatric Hematology-Oncology
;
: 184-187, 2016.
Artículo
en Inglés
| WPRIM
| ID: wpr-788575
ABSTRACT
Ataxia-telangiectasia (AT) is characterized by cerebellar ataxia, progressive immunodeficiency, radiation sensitivity, telangiectasia, and predisposition to malignancy. AT patients have a 100-fold increased risk for the development of lymphoid malignancies. It is important to consider AT in a child with pre-existing ataxia, or lymphoid malignancy that was diagnosed at a younger age than expected. This consideration avoids the confusion between ataxia development and toxicity from chemotherapy. Hodgkin's lymphoma (HL) is usually treated with chemotherapy and/or radiotherapy. Unfortunately, when treated with conventional doses of radiotherapy, AT patients invariably experience devastating necrosis of their normal tissues. Therefore, a new treatment protocol for patients with HL in AT must be established. In this paper, we report the case of an 8-year-old female patient with HL in AT who was treated with chemotherapy. This patient was also treated with brentuximab (which targets CD30) for salvage therapy after the disease progressed.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Tolerancia a Radiación
/
Radioterapia
/
Ataxia
/
Telangiectasia
/
Ataxia Telangiectasia
/
Enfermedad de Hodgkin
/
Ataxia Cerebelosa
/
Protocolos Clínicos
/
Terapia Recuperativa
/
Quimioterapia
Tipo de estudio:
Guía de Práctica Clínica
Límite:
Niño
/
Femenino
/
Humanos
Idioma:
Inglés
Revista:
Clinical Pediatric Hematology-Oncology
Año:
2016
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS